8-K
filed May 26, 2023, 7:59 PM ET
CIK 0001365916
regulatory
confidence high
sentiment negative
materiality 0.75
AMYRIS, INC.: Nasdaq/NYSE listing notice — Amyris receives Nasdaq bid price deficiency notice; shareholders approve authorized share increase
AMYRIS, INC.
- Nasdaq notified Amyris that its stock had a closing bid below $1.00 for 30 consecutive days, triggering a 180-day grace period until Nov 22, 2023.
- Company can regain compliance if bid price closes at $1.00+ for ten consecutive business days before deadline; reverse stock split considered.
- At May 25 annual meeting, shareholders elected four Class I directors and approved increasing authorized common shares from 550M to 750M (total from 555M to 755M).
- Say-on-pay passed with 165.8M votes; frequency set at one year; auditor ratified with 251.1M votes.
Key facts
Extracted from this filing and checked against the source text.
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.9
AMYRIS, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).
- Exchange
- nasdaq
- Notice
- deficiency notice
- Deficiency
- minimum bid price
- Rules
- 5450(a)(1)
Exact text from the filing
May 26, 2023, Amyris, Inc. (the “Company”) received a deficiency letter from the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company’s common stock has been below the minimum $1.00 per share required for continued listing on The Nasdaq Global Select Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”). The Nasdaq deficiency letter has no immediate effect on the listing of the Company’s common stock which wil
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
AMYRIS, INC. shareholders approved Amendment to certificate of incorporation to increase authorized shares from 555,000,000 to 755,000,000 total, and common stock from 550,000,000 to 750,000,000 at the 2023-05-25 meeting.
- Proposal
- charter amendment
- Outcome
- passed
- Meeting
- 2023-05-25
Exact text from the filing
Proposal 5 was approved by the following vote: For Against Abstain Broker Non-Vote 224,199,363 44,951,062 2,359,193 —
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
AMYRIS, INC. shareholders approved Non-binding advisory vote on compensation of named executive officers at the 2023-05-25 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-05-25
Exact text from the filing
Proposal 3 was approved by the following vote: For Against Abstain Broker Non-Vote 165,826,409 22,137,785 2,412,447 81,132,977
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
AMYRIS, INC. shareholders approved Advisory vote on frequency of future say-on-pay votes at the 2023-05-25 meeting.
- Proposal
- say on pay frequency
- Outcome
- passed
- Meeting
- 2023-05-25
Exact text from the filing
The "every one year" option in Proposal 4 was approved by the following vote: One Year Two Years Three Years Abstain Broker Non-Vote 178,361,147 1,450,941 3,191,815 7,372,738 81,132,977
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
AMYRIS, INC. shareholders approved Election of four Class I directors: Ana Dutra, Geoffrey Duyk, James McCann, Steven Mills at the 2023-05-25 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-05-25
Exact text from the filing
On May 25, 2023, the Company held its 2023 Annual Meeting of Stockholders (the “Annual Meeting”) for the following purposes: a. To elect the four Class I directors nominated by the Company’s board of directors (the “Board”) to serve on the Board for a three-year term (“Proposal 1”); b. To ratify the appointment of Macias Gini & O’Connell LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 (“Proposal 2”); c. To approve a non-binding advisory vote on the compensation of our named executive officers (“Proposal 3”); d. To approve a non-binding advisory vote on the frequency of future stockholder say-on-pay votes (“Proposal 4”); e. To approve an amendment to the Company’s certificate of incorporation to increase the number of total authorized shares from 555,000,000 to 755,000,000 and the number of authorized shares of common stock from 550,000,000 to 750,000,000 (“Proposal 5”); and f. To act upon such other matters as may properly
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
AMYRIS, INC. shareholders approved Ratification of Macias Gini & O'Connell LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-05-25 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-05-25
Exact text from the filing
Proposal 2 was approved by the following vote: For Against Abstain Broker Non-Vote 251,075,958 15,477,835 4,955,825 —
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.